Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-065181
Filing Date
2021-11-17
Accepted
2021-11-17 17:25:59
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 27274
  Complete submission text file 0001209191-21-065181.txt   28597
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 FIRSTFIELD ROAD, #250 GAITHERSBURG MD 20878
Business Address
Glenn Gregory M (Reporting) CIK: 0001342823 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 211421603